M Brunet
- Oncology top 5%
- Cancer Research top 2%
- Molecular Biology
- Genetics top 10%
- Pathology and Forensic Medicine top 5%
- Co-authors
- K. HacèneV Le DoussalF. SpyratosSam FriedmanM. Tubiana-HulinC. PalludRosette LidereauEdwin Milgröm
- Topics
- Breast Cancer Treatment Studies (8 papers)HER2/EGFR in Cancer Research (7 papers)Estrogen and related hormone effects (6 papers)
- Partner nations
- FranceCanadaUnited Kingdom
In The Last Decade
M Brunet
25 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 81
- Oncology 763
- Cancer Research 709
- Molecular Biology 471
- Genetics 326
- Pathology and Forensic Medicine 254
Countries citing papers authored by M Brunet
This map shows the geographic impact of M Brunet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Brunet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Brunet more than expected).
Fields of papers citing papers by M Brunet
This network shows the impact of papers produced by M Brunet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Brunet. The network helps show where M Brunet may publish in the future.
Co-authorship network of co-authors of M Brunet
This figure shows the co-authorship network connecting the top 25 collaborators of M Brunet. A scholar is included among the top collaborators of M Brunet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Brunet. M Brunet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 165 | |
| 2 | 7 | |
| 3 | 100 | |
| 4 | 51 | |
| 5 | 15 | |
| 6 | 19 | |
| 7 | 47 | |
| 8 | 4 | |
| 9 | 299 | |
| 10 | 34 | |
| 11 | 34 | |
| 12 | 268 | |
| 13 | Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas. | 187 |
| 14 | 76 | |
| 15 | [Cancer of the prostate. Epidemiologic evaluation, incidence, and trends, especially in France]. | 1 |
| 16 | Prognostic index for clinical Stage I cutaneous malignant melanoma. | 25 |
| 17 | Relationship of presence of progesterone receptors to prognosis in early breast cancer. | 141 |
| 18 | [Mortality of bladder cancer in France: 1952--1976. Trends and increase, particularly in the South of France (author's transl)]. | 2 |
| 19 | [Breast cancer in man]. | 5 |
| 20 | Hydroxyproline in urine of children. Normal and pathological values: preliminary study based on 200 estimations. | 1 |
About M Brunet
M Brunet is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 26 papers that have together received 1.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (8 papers), HER2/EGFR in Cancer Research (7 papers) and Estrogen and related hormone effects (6 papers). The work is most often cited by research in Cancer Research (709 citations), Oncology (763 citations) and Immunology and Allergy (127 citations). M Brunet has collaborated with scholars based in France, Canada and United Kingdom. Frequent co-authors include K. Hacène, V Le Doussal, F. Spyratos, Sam Friedman, M. Tubiana-Hulin, C. Pallud, Rosette Lidereau, Edwin Milgröm, J Gest and Marie-France Pichon. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.